documents: FDA-2013-D-1444-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1444-0001 | FDA | FDA-2013-D-1444 | Draft Guidance; Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Withdrawal of Guidances | Notice | Notice of Availability | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-02-04T04:59:59Z | 2014-02-05T02:03:21Z | 2013-28963 | 0 | 0 | 09000064814a6225 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref